Atlas Trials

Metastatic Head and Neck Cancer

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Head and Neck Cancer

RecordFirmDate
BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36) (NCT04969861)Nektar Therapeutics2022-03-09
Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers (NCT05091190)Hospices Civils de Lyon2021-10-27
Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC (NCT05057247)Glenn J. Hanna2021-10-14
A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers (NCT04902027)CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2021-07-01
Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC (NCT04260126)PDS Biotechnology Corp.2021-03-29
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 (NCT04534205)BioNTech SE2021-01-07
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors (NCT03991741)Gregory Daniels2020-10-07
Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer (NCT03937141)Chinook Therapeutics, Inc. (formerly Aduro)2019-08-26
Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers (NCT03323424)Institut de Cancérologie de la Loire2019-01-01
Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG) (NCT03146338)Weprom2017-07-04
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) (NCT02358031)Merck Sharp & Dohme LLC2015-03-19
A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes (NCT01620242)UNICANCER2012-04-01
Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer (NCT00088907)National Cancer Institute (NCI)2004-08-01

Track Metastatic Head and Neck Cancer automatically

Every clearance here is in the API, with alerts when new ones post.